Immunovant Inc.

IMVT | NASDAQ

Price Alert Chart Builder DCF Calculator

$37.18

+$0.23 (+0.62%)

At close: Sep 21, 2026, 4:00 PM ET

$37.51

+$0.33 (+0.89%)

Pre-market: Sep 22, 2026, 8:46 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q1 2027 Jun 29, 2026	Q4 2026 Mar 30, 2026	Q3 2026 Dec 30, 2025	Q2 2026 Sep 29, 2025	Q1 2026 Jun 29, 2025	Q4 2025 Mar 30, 2025	Q3 2025 Dec 30, 2024	Q2 2025 Sep 29, 2024	Q1 2025 Jun 29, 2024	Q4 2024 Mar 30, 2024	Q3 2024 Dec 30, 2023	Q2 2024 Sep 29, 2023	Q1 2024 Jun 29, 2023	Q4 2023 Mar 30, 2023	Q3 2023 Dec 30, 2022	Q2 2023 Sep 29, 2022	Q1 2023 Jun 29, 2022	Q4 2022 Mar 30, 2022	Q3 2022 Dec 30, 2021	Q2 2022 Sep 29, 2021	Q1 2022 Jun 29, 2021
Revenue	7.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	101K	105K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	7.1M	n/a	-101K	-105K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-153.23M	-159.55M	-114.36M	-131.76M	-127.22M	-113.83M	-114.3M	-115.74M	-94.28M	-80.88M	-61.55M	-61.8M	-65.98M	-64.26M	-54.03M	-49.61M	-40.38M	-47.23M	-41.27M	-37.65M	-29.89M
Interest Income	n/a	8.06M	5.33M	5.6M	6.34M	6.89M	4.59M	6.07M	7.18M	8.38M	8.93M	3.57M	4.07M	3.48M	2.94M	1.15M	n/a	n/a	n/a	n/a	n/a
Pretax Income	-153.22M	-150.7M	-109.08M	-125.91M	-119.7M	-105.87M	-110.97M	-109.04M	-87.07M	-75.09M	-51.53M	-58.21M	-73.95M	-60.42M	-62.84M	-47.67M	-40.02M	-47.18M	-41.39M	-37.73M	-30.51M
Net Income	-153.22M	-147.86M	-110.64M	-126.5M	-120.61M	-106.45M	-111.12M	-109.12M	-87.15M	-75.32M	-51.42M	-58.66M	-73.94M	-59.43M	-63.23M	-47.93M	-40.37M	-47.17M	-41.39M	-37.7M	-30.47M
Selling & General & Admin	17.69M	17.27M	15.44M	17.51M	26.02M	20.17M	19.78M	18.47M	18.81M	14.82M	13.22M	13.84M	15.4M	12.42M	11.78M	11.88M	11.95M	15.24M	11.52M	16.29M	11.18M
Research & Development	142.63M	142.29M	98.92M	114.25M	101.2M	93.65M	94.52M	97.27M	75.47M	66.06M	48.34M	47.96M	50.58M	51.84M	42.25M	37.74M	28.43M	31.99M	29.76M	21.36M	18.71M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	160.32M	159.55M	114.36M	131.76M	127.22M	113.83M	114.3M	115.74M	94.28M	80.88M	61.55M	61.8M	65.98M	64.26M	54.03M	49.61M	40.38M	47.23M	41.27M	37.65M	29.89M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	160.32M	159.55M	114.36M	131.76M	127.22M	113.83M	114.3M	115.74M	94.28M	80.88M	61.55M	61.8M	65.98M	64.26M	54.03M	49.61M	40.38M	47.23M	41.27M	37.65M	29.89M
Income Tax Expense	n/a	-2.84M	1.55M	594K	913K	583K	152K	78K	77K	232K	-108K	454K	-11K	-991K	387K	261K	352K	-12K	n/a	-31K	-41K
Shares Outstanding (Basic)	205.55M	203.71M	181.51M	173.64M	170.87M	151.57M	146.92M	146.47M	146.09M	145.36M	144.52M	131.16M	130.5M	129.63M	128.57M	116.57M	116.56M	116.34M	115.03M	109.08M	97.98M
Shares Outstanding (Diluted)	205.55M	203.71M	181.51M	173.64M	170.87M	151.57M	146.92M	146.47M	146.09M	145.36M	144.52M	131.16M	130.5M	129.63M	128.57M	116.57M	116.56M	116.34M	115.03M	109.08M	97.98M
EPS (Basic)	-0.75	-0.73	-0.61	-0.73	-0.71	-0.64	-0.76	-0.74	-0.60	-0.52	-0.36	-0.45	-0.57	-0.46	-0.49	-0.41	-0.35	-0.41	-0.36	-0.35	-0.31
EPS (Diluted)	-0.75	-0.73	-0.61	-0.73	-0.71	-0.64	-0.76	-0.74	-0.60	-0.52	-0.36	-0.45	-0.57	-0.46	-0.49	-0.41	-0.35	-0.41	-0.36	-0.35	-0.31
EBITDA	-153.13M	-150.6M	-108.98M	-125.8M	-119.59M	-105.76M	-110.87M	-108.95M	-86.99M	-75.02M	-51.47M	-58.15M	-73.9M	-60.37M	-62.79M	-47.62M	-39.98M	-47.14M	-41.35M	-37.71M	-30.49M
EBIT	-153.22M	-150.7M	-109.08M	-125.91M	-119.7M	-105.87M	-110.97M	-109.04M	-87.07M	-75.09M	-51.53M	-58.21M	-73.95M	-60.42M	-62.84M	-47.67M	-40.02M	-47.18M	-41.39M	-37.73M	-30.51M
Depreciation & Amortization	92K	96K	101K	105K	107K	109K	99K	89K	80K	64K	58K	56K	53K	54K	49K	46K	44K	39K	33K	28K	26K